Related references
Note: Only part of the references are listed.A case of adult Pompe disease presenting with severe fatigue and selective involvement of type 1 muscle fibers
Linda E. M. van den Berg et al.
NEUROMUSCULAR DISORDERS (2011)
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
S. Strothotte et al.
JOURNAL OF NEUROLOGY (2010)
Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy
Nina Raben et al.
MOLECULAR GENETICS AND METABOLISM (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
Priya S. Kishnani et al.
PEDIATRIC RESEARCH (2009)
Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease
Maarten R. Drost et al.
MUSCLE & NERVE (2008)
Clinical features of late-onset Pompe disease: A prospective cohort study
John H. J. Wokke et al.
MUSCLE & NERVE (2008)
Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease
C. I. van Capelle et al.
NEUROMUSCULAR DISORDERS (2008)
Therapeutic approaches in glycogen storage disease type II/Pompe disease
Benedikt Schoser et al.
NEUROTHERAPEUTICS (2008)
Late onset Pompe disease:: Clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients
Wolfgang Muller-Felber et al.
NEUROMUSCULAR DISORDERS (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease
Beth L. Thurberg et al.
LABORATORY INVESTIGATION (2006)
A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease
Priya S. Kishnani et al.
JOURNAL OF PEDIATRICS (2006)
The natural course of non-classic Pompe's disease; a review of 225 published cases
LPF Winkel et al.
JOURNAL OF NEUROLOGY (2005)
Replacing acid alpha-glucosidase in Pompe disease: Recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers
N Raben et al.
MOLECULAR THERAPY (2005)
Long term intravenous treatment of Pompe disease with recombinant human α-glucosidase from milk
JMP Van den Hout et al.
PEDIATRICS (2004)
Enzyme replacement therapy in the mouse model of Pompe disease
N Raben et al.
MOLECULAR GENETICS AND METABOLISM (2003)
The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature
HMP van den Hout et al.
PEDIATRICS (2003)
Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy
LPF Winkel et al.
MUSCLE & NERVE (2003)
Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II
RP Hesselink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2003)
Characteristics of myofibres in the masseter muscle of mice during postnatal growth period
K Gojo et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2002)
Share Paper
